Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
Tracey G SimonDaniel E SingerYichi ZhangJulianna M MastrorilliAlexander CervoneElyse DiCesareKueiyu Joshua LinPublished in: Annals of internal medicine (2024)
National Institutes of Health.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- direct oral anticoagulants
- catheter ablation
- left atrial
- public health
- left atrial appendage
- venous thromboembolism
- healthcare
- heart failure
- quality improvement
- mental health
- percutaneous coronary intervention
- health information
- health promotion
- coronary artery disease
- risk assessment
- climate change
- acute coronary syndrome
- social media